Pall to Unveil Latest Additions to its Purification and Filtration Portfolio
Pall is set to display its latest purification and filtration solutions for the semiconductor industry at the SEMICON West exposition to be held in San Francisco between July 10 and 12.
The new line of products will facilitate defect reduction in gas, chemical, ultrapure water, chemical mechanical polishing (CMP) and photolithography applications.
For ultra-high-purity gas applications, Pall has developed the Gaskleen II EL purifier assembly for intermittent process flows of 50 standard liters per minute. Level of molecular contaminants like oxygen and hydrocarbons can be reduced to less than 1 part per billion from a number of gases by filling the assembly with Pall’s AresKleen purification materials. The second product in this line is the ChamberKleen diffusers equipped with NW40 and NW50 flanges. The diffusers facilitate load lock venting for allowing the flow of large volume of gas in a short period and the incorporated filter-pack eliminates particles bigger than 3 nm. The chemical filter line-up includes the Ultipeat SP DR G2 filter and Ultikleen G3 HiT KC Assembly. The former can filter out particles as small as 10 nm and the latter can eliminate particles smaller than 20 nm under very high temperatures.
The Ionkleen CAF purifier is the latest addition to the ultrapure water application segment. The filter can reduce trace metal ions concentration to less than 1 parts per trillion and facilitate a 20-liters per minute flow rate. The Profile nano filter is for use in advanced CMP processes such as barrier copper and shallow trench isolation. With particle removal efficiency higher than 99 percent at 200 nm, the filter can isolate both colloidal silica slurries with low solids and ceria. For photolithography applications, the company has introduced the 2 nm PE-kleen filter and Nylon Extension filters in a range of capsule and cartridge configurations.
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.
Written by
Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing.
When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Thomas, G.P.. (2019, February 12). Pall to Unveil Latest Additions to its Purification and Filtration Portfolio. AZoNano. Retrieved on February 12, 2026 from https://www.azonano.com/news.aspx?newsID=25173.
MLA
Thomas, G.P.. "Pall to Unveil Latest Additions to its Purification and Filtration Portfolio". AZoNano. 12 February 2026. <https://www.azonano.com/news.aspx?newsID=25173>.
Chicago
Thomas, G.P.. "Pall to Unveil Latest Additions to its Purification and Filtration Portfolio". AZoNano. https://www.azonano.com/news.aspx?newsID=25173. (accessed February 12, 2026).
Harvard
Thomas, G.P.. 2019. Pall to Unveil Latest Additions to its Purification and Filtration Portfolio. AZoNano, viewed 12 February 2026, https://www.azonano.com/news.aspx?newsID=25173.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.